AzTrials
AzTrials

Stroke, IschemicSWIFTNCT06709898

Stroke in Working Age and Job Accommodation in Facilitating Transition Back to Work

A study testing Cognitive job accommodation in people with Stroke, Ischemic and Cognitive Impairment, run by Finnish Institute of Occupational Health at 1 site in Finland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this randomized controlled trial (RCT) is to investigate whether cognitive job accommodation intervention enhances return to work, work ability and performance after ischemic stroke in working-age population. Read more about this study

Who is it for?
Ages 18 to 68 years
What is being tested?
Cognitive job accommodation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteFinland
Study dates
10 Jan 2025to 30 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 68 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Ischemic stroke occurred within 12 month
  • At least mild cognitive, emotional and/or state alertness symptoms detected in neuropsychological assessment in subacute phase
  • Employed when the stroke occurred and has workplace where to return
  • Occupational health services (OHS) available
  • Participant has agreed that clinical neuropsychologist and researcher can participate to OHS consultation regarding the job accommodation
  • Adequate Finnish language ability to the questionnaires and cognitive tests

Who cannot join

  • Work status - professional driver or some other safety critical occupation where even mild cognitive impairments restrict return to work
  • Former neurological or psychiatric disorder or developmental disability affecting significantly cognition

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Teemu I Paajanen, Dr contact

+358438250389

teemu.paajanen@ttl.fi

Nina Nevala, Dr contact

nina.nevala@ttl.fi

Finland1 site, 1 recruiting
  • Helsinki University Hospital Stroke Unit

    Helsinki, Uusimaa, 00029

    Jukka Putaala, Associate Professor, +358 40 6897703, jukka.putaala@hus.fi

    Recruiting

Other trials in Finland

About this study

The aim of this randomized controlled trial (RCT) is to investigate whether cognitive job accommodation intervention enhances return to work, work ability and performance after ischemic stroke in working-age population. The main questions are:

  • Does the cognitive job accommodation intervention affect absenteeism and presenteeism after stroke?
  • Does the intervention affect work ability and perceived cognitive and emotional difficulties at work?
  • Does the intervention decrease mental strain, fatigue and negative mood symptoms after return to work?
  • Does the intervention affect life satisfaction among the stroke patients returning to work?
Read more

Researchers will compare the intervention group to a control group returning to work after stroke with current healthcare practices and work procedures.

Participants:

  • At baseline, 6 and 12 month follow-up web-based questionnaires and cognitive tests are administered.
  • At 3 month follow-up participants fill in Brain Work Questionnaire (BWQ) that measures cognitive demands and difficulties at work.
Read the detailed description

Introduction: Strokes are one of the most significant conditions affecting cognition among working-age adults. Incidence of stroke increases in older age and due to the lengthening of working careers, more people are experiencing strokes while still employed. Additionally, the incidence of strokes among younger workers has increased over recent decades. In Finland, 2000 - 3000 work-aged persons suffer a stroke annually. The majority experiences cognitive or emotional symptoms post-stroke, and for about half of them, these symptoms become long-lasting or permanent. The cognitive demands of modern work have steadily increased, and the severity of cognitive symptoms has been shown to strongly predict the likelihood of returning to work after a stroke. While job accommodation has been shown to be an effective way to support return to work after many illnesses, there is limited research on its benefits following a stroke. Furthermore, there is lack of research on cognitive job accommodation, despite health professionals finding it particularly challenging.

Aims: To evaluate the effect of job accommodations after stroke on various work and health related outcomes. In addition, information about working-aged stroke patients returning to work and the practices of job accommodation is provided. In the future these results can potentially be applied also to other conditions affecting cognition.

Participants and methods: This study will recruit 18-68 year old stroke patients who are returning to work (n ≈ 100). Participants will be randomized into either a job accommodation intervention group or a control group. The study will assess the benefits of cognitive job accommodation in terms of absenteeism, presenteeism, work modifications, perceived work ability, health indicators and cognitive and emotional symptoms. Participants will be followed through web-based surveys and novel cognitive tests over a 12-month period. The study will adopt a multidisciplinary approach (ergonomics, occupational psychology, neuropsychology, and medicine) and will be based on the International Classification of Functioning, Disability, and Health (ICF) model. Cognitive job accommodation will utilize an established model, a design form, and an instructional video.

Collaborators and target organizations: The research will be conducted in collaboration with the Helsinki University Hospital Neurocenter and the Finnish Institute of Occupational Health. In addition to these organizations the study is funded by the Finnish Work Environment Fund. The target organizations include occupational health services and workplaces of stroke survivors.

Utilization of Results: The methods developed in this study can be used in future collaborations between workplaces, occupational health services, and specialized healthcare. The findings can also be applied to other conditions that cause cognitive difficulties and require job accommodation.

Being tested
Cognitive job accommodation
Keywords
Stroke, Cognitive impairment, Return to work, Job accommodation, Work ability, Neuropsychology
Medical subject headings
Ischemic Stroke, Cognitive Dysfunction, Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive job accommodationOther

    Job accommodation focused on the cognitive aspects at work

Study groups in NCT06709898
Study groupRoleWhat they receive
Cognitive job accommodationExperimental* In intervention neuropsychological information will be individually processed and transferred systematically from the neurological unit to occupational health service (OHS) to help design the individually tailored work modifications. * Information of the job accommodation will be given to employers. * Cognitive job accommodation is carried out at the workplace in cooperation between the employer, employee and OHS. * Feedback of the cognitively challenging work traits will be given to participants after returning to work.
Receives: Other: Cognitive job accommodation
Reference groupNo interventionEmployees return to work according to standard health care and workplace procedures.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Absenteeism and presenteeism

    Absenteeism and presenteeism are evaluated with World Health Organization's Health and Work Performance Questionnaire (HPQ) using both absolute and relative measures. Absolute absenteeism: hours in 4 week (higher value indicates worse outcome). Absolute presenteeism: single question measure of own job performance (score 0-10) analyzed according to the HPQ instructions (higher value indicates better outcome). Relative absenteeism: working hours in 4 week / expected working hours in 4 week. Relative presenteeism: evaluation of own job performance (score 0-10) / evaluation of most other workers job performance (score 0-10). This score is restricted to the range of 0.25 to 2.0 according to HPQ instructions. In both relative scores higher values indicate better outcome.

    Measured: 6 and 12 months

  2. Work ability

    Estimate of the current work ability measured with single question (score range 0-10, higher score indicate better outcome) from Work Ability Index. Estimate of future work ability measured with single question (categorical variable: yes, no, maybe) from Work Ability Index.

    Measured: 6 and 12 months

Secondary outcomes (18)
  1. Perceived success in returning to work

    Subjectively evaluated success in returning to work. Single item question with 5 point Likert scale (5= very good; 1= very bad).

    Measured: 6 and 12 months

  2. Cognitive demands of work and related difficulties

    Frequency of different cognitive demands at work and related perceived difficulties measured with Brain Work Questionnaire. Frequency values are reported as averaged occurrence/week (lower values indicate better outcome), and related difficulties in ordinal response variable (0=no difficulties, 1=sometimes difficult, 2=often difficult). Higher value indicates worse outcome.

    Measured: 3 and 12 months

  3. Cognitive symptoms at work

    Cognitive symptoms at work measured with The Cognitive Function at Work Questionnaire total score (score range 0-58: higher value indicates worse outcome)

    Measured: 6 and 12 months

  4. Stress

    Estimates of perceived stress. General stress measured with single item stress question (score range 1-5, lower value indicates better outcome). Theme specific stress (at home, work and financial). Ordinal 4 point response scales. Questions from INTERSTROKE study.

    Measured: 6 and 12 months

  5. Sick leave days

    Number of days on sick leave after returning to work. Higher value indicates worse outcome.

    Measured: 6 and 12 months

  6. Insomnia symptoms

    Frequency of insomnia symptoms measured with single item question with ordinal 5 point scale (5=Every night or nearly every night; 1=never). Higher value indicates worse outcome.

    Measured: 6 and 12 months

  7. Fatigue symptoms

    Fatigue symptoms measured with Fatigue Assessment Scale (FAS). Total score range 10-50. Higher score indicates worse outcome.

    Measured: 6 and 12 months

  8. Stroke related life satisfaction

    Perceived life satisfaction based on the Young Stroke Questionnaire (total score 0-100; where higher score indicates better outcome)

    Measured: 6 and 12 months

  9. Mental job strain

    Perceived mental job strain. Single item question with ordinal 1-5 point response scale (1=not at all; 5 very much). Higher value indicates worse outcome.

    Measured: 6 and 12 months

  10. Perceived cognitive and emotional difficulties in general

    Perceived cognitive and emotional difficulties in general measured with Check List for Cognitive and Emotional Consequences. Likert scale questions 0-2. Higher values indicate worse outcome.

    Measured: 6 and 12 months

  11. Modified Rankin scale

    The Modified Rankin Scale (mRS) measures degree of disability/dependence after a stroke. The mRS is a 6 point disability scale with possible scores ranging from 0 to 5. Higher score indicates worse outcome.

    Measured: 12 months from the stroke

  12. Benefit of the job accommodations

    Perceived benefit of the carried out job accommodations. Single item question with 5 point Likert scale (5=very much; 1=very little). Higher value indicates better outcome.

    Measured: 6 and 12 months

  13. Job burnout symptoms

    Job burnout symptoms measured with Burnout Assessment Tool (BAT) 4-item version. Averaged sum score: range 1-5. Higher score indicates worse outcome.

    Measured: 6 and 12 months

  14. Depression symptoms

    Depression symptoms measured with Patient health Questionnaire 9 question version (PHQ-9). Total score range 0-27. Higher score indicates worse outcome.

    Measured: 6 and 12 months

  15. General life satisfaction

    Perceived general life satisfaction measured with single item question with 5 point Likert scale (5=very satisfied; 1=very dissatisfied). Higher score indicates better outcome.

    Measured: 6 and 12 months

  16. Daily function ability

    Perceived daily ability to function measured with single item question (score range 0-10). Higher score indicates better outcome.

    Measured: 6 and 12 months

  17. Amount of job accommodations

    Amount of the actualized job accommodations measured with single item question. Ordinal 4 item scale. (3=A lot , 2=somewhat, 1=a little, 0=not at all). Higher value indicates better outcome.

    Measured: 6 and 12 months

  18. Work participation

    Monthly work participation percentage (%) as compared to fulltime working. Higher value indicate better outcome.

    Measured: 6 and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Nov 2024
  2. Study start10 Jan 2025
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized clinical trial
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06709898
Sponsor's protocol ID
4011001
Acronym
SWIFT
Status last verified
Mar 2025
First submitted
19 Nov 2024
Last updated
13 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: IPD not shared

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive job accommodation in people with Stroke, Ischemic and Cognitive Impairment, run by Finnish Institute of Occupational Health at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Teemu I Paajanen, Dr (+358438250389, teemu.paajanen@ttl.fi), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Absenteeism and presenteeism (time frame: 6 and 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in